Evidence map›Paper›PMID 23907729›Full record

ReviewNeuromolecular medicine2013

Protein sumoylation in brain development, neuronal morphology and spinogenesis.

Carole Gwizdek, Frédéric Cassé, Stéphane Martin

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neuromolecular medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Commentary: Analysis of SUMO1-conjugation at synapses.Frontiers in cellular neuroscience · 2017
    Article
  15. Article
  16. Sumoylation in Synaptic Function and Dysfunction.Frontiers in synaptic neuroscience · 2016
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Carole GwizdekInstitut de Pharmacologie Moléculaire et Cellulaire, Laboratory of Excellence 'Network for Innovation on Signal Transduction Pathways in Life Sciences', UMR7275, Centre National de la Recherche Scientifique, University of Nice-Sophia-Antipolis, 660 route des lucioles, 06560, Valbonne, France.
Frédéric Cassé
Stéphane Martin
Centre National de la Recherche Scientifique · FRInstitut de Pharmacologie Moléculaire et Cellulaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small ubiquitin-like modifiers (SUMOs) are polypeptides resembling ubiquitin that are covalently attached to specific lysine residue of target proteins through a specific enzymatic pathway. Sumoylation is now seen as a key posttranslational modification involved in many biological processes, but little is known about how this highly dynamic protein modification is regulated in the brain. Disruption of the sumoylation enzymatic pathway during the embryonic development leads to lethality revealing a pivotal role for this protein modification during development. The main aim of this review is to briefly describe the SUMO pathway and give an overview of the sumoylation regulations occurring in brain development, neuronal morphology and synapse formation.

Indexed as

AnimalsBasic-Leucine Zipper Transcription FactorsBrainEmbryonic DevelopmentEukaryotic CellsEye ProteinsGuanylate KinasesHumansMEF2 Transcription FactorsMiceMice, KnockoutMice, TransgenicNerve Tissue ProteinsNeurogenesisNeuronal PlasticityPaired Box Transcription FactorsBasic-Leucine Zipper Transcription FactorsCASK kinasesEye ProteinsGuanylate KinasesMEF2 Transcription Factorsmetabotropic glutamate receptor 8Nerve Tissue ProteinsPaired Box Transcription FactorsReceptors, Metabotropic GlutamateSmall Ubiquitin-Related Modifier ProteinsUbiquitin-Protein Ligase Complexes

Identifiers

PMID23907729
OpenAlexW2051794025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.